A Study of Participants With Advanced Prostate Cancer in Canada
NCT03501173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 374
Last updated 2023-07-25
Summary
The purpose of this study is to document the course of advanced prostate cancer in Canada in terms of disease progression, real-world treatment, and patient management.
Conditions
- Prostatic Neoplasms
Interventions
- OTHER
-
Standard of Care
Participants will not receive any intervention in this study. Participants will receive standard of care therapy.
Sponsors & Collaborators
-
Janssen Inc.
lead INDUSTRY
Principal Investigators
-
Janssen Inc. Clinical Trial · Janssen Inc.
Eligibility
- Min Age
- 21 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-12
- Primary Completion
- 2023-07-14
- Completion
- 2023-07-14
Countries
- Canada
Study Locations
More Related Trials
-
A Web-based Peer Navigation Program for Men With Prostate Cancer
NCT05041504 ·Status: COMPLETED ·Phase: NA
-
Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer
NCT06585007 ·Status: RECRUITING ·Phase: PHASE3
-
PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer
NCT04557501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation Procedures
NCT02936258 ·Status: UNKNOWN ·Phase: NA
-
Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer
NCT01368055 ·Status: COMPLETED ·Phase: NA
-
Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer
NCT05313815 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Targeted Prostate Biopsies Under MRI: Tolerance and Contribution in the Therapeutic Decision - Exploratory Study
NCT05612204 ·Status: RECRUITING ·Phase: NA
-
18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer
NCT04733768 ·Status: COMPLETED ·Phase: PHASE2
-
PSMA-PET/CT Registry
NCT05709535 ·Status: TERMINATED
-
Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer
NCT02077335 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Tracer-Guided Surgery for Recurrent Prostate Cancer
NCT05555017 ·Status: RECRUITING ·Phase: PHASE2
-
Hypofractionated Proton Beam Therapy for Localized Prostate Cancer
NCT01950351 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer
NCT05712174 ·Status: TERMINATED ·Phase: PHASE2
-
Prostate Cancer Screening Trial Using Imaging
NCT03702439 ·Status: COMPLETED
-
PSMA-PET Registry for Recurrent Prostate Cancer
NCT03718260 ·Status: RECRUITING ·Phase: NA
-
Imaging of High Grade Prostate Cancer
NCT02177526 ·Status: TERMINATED ·Phase: NA
-
Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients
NCT01488968 ·Status: TERMINATED ·Phase: NA
-
Prostate Cancer Patient Management With 18F-DCFPyL PET/CT
NCT03459820 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer
NCT00126165 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR
NCT03149861 ·Status: COMPLETED ·Phase: NA
-
Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
NCT00967889 ·Status: UNKNOWN
-
Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer
NCT05328505 ·Status: RECRUITING ·Phase: NA
-
Protons Vs. Photons for High-risk Prostate Cancer
NCT05350475 ·Status: RECRUITING ·Phase: NA
-
Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanning
NCT01950871 ·Status: TERMINATED ·Phase: PHASE4
-
Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers
NCT03585114 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2